logo

Regeneron Saratoga Springs Drug Manufacturing Facility

Planned · New York · Last reported Dec 2025

Source: The Business Journals

Project
Planned

Regeneron plans to adapt the former Quad plant in Saratoga Springs for drug manufacturing. The project involves transforming a 1 million-square-foot building in the W.J. Grande Industrial Park to create a $2 billion drug manufacturing facility. The project is expected to create 1,000 new jobs and 500 temporary jobs during construction.

Status
Prospective
Sector
Manufacturing (Industrial), Government, Commercial
Location
Saratoga Springs, New York, United States of America
Updated
22 Jul 2026
Source
The Business Journals

ConstructChat

Ask ConstructChat about Regeneron Saratoga Springs Drug Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Regeneron Saratoga Springs Drug Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Saratoga Springs, New York, United States. Taiyo aggregates data on it from The Business Journals.

Participants

Sponsoring Agency

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Regeneron plans to adapt the former Quad plant in Saratoga Springs for drug manufacturing. The project involves transforming a 1 million-square-foot building in the W.J. Grande Industrial Park to create a $2 billion drug manufacturing facility. The project is expected to create 1,000 new jobs and 500 temporary jobs during construction.

Original sector

Manufacturing

Budget

Location

Country

United States of America (USA)

State

New York

City

Saratoga Springs

Source

Source

The Business Journals

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Government, Commercial

Article published date

2025-12-20

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project